NK

Nirmala Krishnrao Nasre

Active Director Additional Director DIN 10663953
DIN 10663953 First appointment Jun 2024 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nirmala Krishnrao Nasre

Data last updated:

Nirmala Krishnrao Nasre is an Additional Director at Eomma Biotek Private Limited (since 2024). The company operates in Wood.

DIN 10663953
Primary Designation Additional Director
Industry Wood
First Appointment 11 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eomma Biotek Private Limited U20236MH2024PTC419594
Additional Director11 Jun 20242024Active

Board colleagues of Nirmala Krishnrao Nasre

Directorship timeline

Open interactive timeline →
Eomma Biotek Private Limited
Premium access

Shareholding and investment profile for Nirmala Krishnrao Nasre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirmala Krishnrao Nasre

Nirmala Krishnrao Nasre currently holds 1 directorship: Eomma Biotek Private Limited (Additional Director, since 11 Jun 2024).

Nirmala Krishnrao Nasre was first appointed on 11 Jun 2024 as Additional Director at Eomma Biotek Private Limited.

The current boards of Nirmala Krishnrao Nasre's companies include Aishwarya Anil Bangadkar (Eomma Biotek Private Limited), Atul Krishnarao Nasre (Eomma Biotek Private Limited), Snehal Prasad Potdukhe (Eomma Biotek Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available